ANTI-HUMAN P16 Chemische Eigenschaften,Einsatz,Produktion Methoden

Verwenden

All Prestige Antibodies Powered by Atlas Antibodies are developed and validated by the Human Protein Atlas (HPA) project (www.proteinatlas.org)and as a result, are supported by the most extensive characterization in the industry.

The Human Protein Atlas project can be subdivided into three efforts: Human Tissue Atlas, Cancer Atlas, and Human Cell Atlas. The antibodies that have been generated in support of the Tissue and Cancer Atlas projects have been tested by immunohistochemistry against hundreds of normal and disease tissues and through the recent efforts of the Human Cell Atlas project, many have been characterized by immunofluorescence to map the human proteome not only at the tissue level but now at the subcellular level. These images and the collection of this vast data set can be viewed on the Human Protein Atlas (HPA) site by clicking on the Image Gallery link. To view these protocols and other useful information about Prestige Antibodies and the HPA, visit .

ANTI-HUMAN P16 Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

ANTI-HUMAN P16 Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.

Firmenname	Telefon	E-Mail	Land	Produktkatalog	Edge Rate
Sigma-Aldrich	021-61415566 800-8193336	orderCN@merckgroup.com	China	51395	80
Shanghai guandao biology engineering co., ltd	18818239863 18818239863;	3171921642@qq.com	China	9260	58
Atlas antibodies	--	order@atlasantibodies.com	China	6586	58
Merck Millipore	--	bioscience@merckgroup.com	China	6839	58
Merck KGaA	--	ordercn@merckgroup.com	China	6394	58
Nanjing Weiwo Biotechnology Co., Ltd.	--		CHINA	6423	58
Guangzhou Guanfeng Biotechnology Co., Ltd.	--		CHINA	1353	58

---

• P16 (AB-1) MONOCLONAL ANTIBODY
• P16 (AB-2) POLYCLONAL ANTIBODY
• Anti-ATL1 antibody produced in rabbit
• Monoclonal Anti-XRCC6BP1 antibody produced in mouse
• Monoclonal Anti-SPG3A antibody produced in mouse
• Anti-CDKN2A (Isoform 1)/P16INK4A antibody produced in goat
• Anti-S100A4/CAPL antibody produced in goat
• Anti-XRCC6BP1 antibody produced in rabbit
• Monoclonal Anti-S100A4 antibody produced in mouse
• ANTI-CDKN2 TUMOR SUPPRESSION PROTEIN
• ANTI-CDKN2
• ANTI-CDK4IN
• ANTI-P16(AB-2), RABBIT SERUM
• ANTI-P16 PROTEIN
• ANTI-P16 PROTEIN, HUMAN
• ANTI-P16 TUMOR SUPPRESSION PROTEIN
• ANTI-P16
• ANTI-MTS1 TUMOR SUPPRESSION PROTEIN
• ANTI-HUMAN P16
• ANTI-HUMAN P16(AB-1)
• ANTI-P16 (AB-1)
• ANTI-P16 (AB-1), HUMAN
• ANTI-P16 (AB-1) MOUSE MAB
• ANTI-P16 (AB-2), HUMAN
• ANTI-P16 (AB-2) RABBIT PAB
• ANTI-P16 (HUMAN)
• ANTI-P16INK4
• ANTI-P16INK4A
• ANTI-MTS1
• ANTI-INK4A
• ANTI-TNK4A TUMOR SUPPRESSION PROTEIN
• Anti-18A2
• Anti-P9KA
• Anti-XRCC6 binding protein 1
• Anti-42A
• Anti-CAPL
• Anti-FSP1
• Anti-KUB3
• Anti-PEL98
• Anti-CDK4 inhibitor
• Anti-Cyclin-dependent kinase inhibitor 2A
• Anti-atlastin GTPase 1
• Anti-ADFSP
• Anti-atlastin1
• Anti-spastic paraplegia 3A (autosomal dominant)
• Anti-HGNC:1787
• Anti-S100 calcium binding protein A4
• Anti-S100A4
• Anti-SPG3A
• Anti-ATL1
• Anti-GBP3
• Anti-SPG3
• Anti-S100 calcium binding protein A4 (calcium protein, calvasculin, metastasin, murine placental homolog)